Skip to main content

Editorial Board

Editors-in-Chief

Lucia Altucci, MD, PhD, Università degli Studi della Campania, Italy
New Content ItemORCID profile
Research website
Twitter@LuciaAltucci
Lucia Altucci studied Medicine & Surgery at Federico II University of Naples, Italy. After obtaining a Specialization degree in Medical Oncology and a PhD degree in molecular and cellular Pathology, she worked as Assistant and later as Associate Professor at the Second University of Naples, Italy. She has been Post-Doc scientist both at the Imperial Cancer Research Fund (ICRF) in London, UK and at the ‘Institut de Génétique et de Biologie Moléculaire et Cellulaire’ (IGBMC) in Strasbourg, France. She is currently Professor of General Pathology and Rector’s delegate for Research & Innovation at University of Campania ‘Luigi Vanvitelli’ in Naples, Italy.
Lucia’s research interests are in: translational medicine (particularly on genome and epigenome deregulation in cancer), stemness, differentiation, cell death processes, and the application of epigenome-based drug discovery approaches in human diseases. As a co-Editor-in-Chief, she is committed to improve the standards of Clinical Epigenetics and to further expand basic and applied epigenetics research at a preclinical and clinical level. Given her medical expertise, she will focus on improving integration of ‘basic’ epigenome knowledge as possible disease-related markers as well as on the potential of chromatin modulation as innovative treatments against human pathologies or as a preventive strategy in predisposed patients.
Specialisms: Epigenetics, Cancer, Programmed cell death, Signal transduction, Innovative therapies

Marianne Rots, MD, University Medical Center Groningen, The Netherlands 
New Content ItemORCID profile
Research website
Marianne Rots studied Medical Biology at the University of Amsterdam, the Netherlands. After obtaining a PhD degree in Medical Oncology in 2000 at the VU Medical Center Amsterdam, she has been a postdoctoral scientist at the Gene Therapy Center of the University of Alabama in Birmingham, AL, USA. In 2001, she was recruited as an Assistant Professor to co-establish the Department of Therapeutic Gene Modulation, School of Pharmacy at the University of Groningen, NL. Appointed as an Associate Professor in 2007, she joined the Department of Pathology and Medical Biology, University Medical Center Groningen, the Netherlands where she currently is Full Professor of Molecular Epigenetics.
Marianne also serves as a vice-chair of the EU H2020 COST Action CM1406 (www.EpiChemBio.eu) and chairs the Program Committee of the Master BioMedical Sciences and Medical Pharmaceutical Sciences at the Faculty of Science and Engineering, University of Groningen. She pioneered epigenetic editing approaches to rewrite epigenetic marks at a given genomic location, allowing to functionally validate epigenetic mutations and to translate these into precision therapeutic targets: “towards the curable epigenome”. As a chief editor, she is committed to maintain the high standards of Clinical Epigenetics and to further expand on the impact of this platform. Her aim is to continue to inform the scientific community on the clinical relevance of epigenetic dysregulations through publishing state of the art research manuscripts. Through the commissioning of reviews or letters to the editors, the communication between clinicians and biologists/chemists is encouraged, while exciting hypotheses can be put forward to stimulate scientific innovation.
Specialisms: Epigenetics, Epigenetic editing


Managing Editor

Federica Sarno, PhD, University Medical Center Groningen, The Netherlands
New Content ItemORCID profile
Research website






Founding Editor
Dr. med. Ulrich Mahlknecht, St Lukas Clinic, Solingen, Germany


Advisory Board

Rui Henrique, MD, PhD, Portuguese Oncology Institute of Porto and Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal

Holger Heyn, PhD, National Center for Genomic Analysis, Center for Genomic Regulation (CNAG-CRG), Barcelona Institute of Science and Technology (BIST), Spain

Caroline Relton, PhD, University of Bristol, UK
New Content ItemORCID profile
Research website
Twitter@carolinerelton
Specialisms: Epigenetics, Epidemiology



Hendrik (Henk) G Stunnenberg, PhD, Princess Máxima Center for Pediatric Oncology, Utrecht and Radboud University Nijmegen,The Netherlands                         


Social Media Editor

Sam El-Osta, PhD, Baker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Australia
New Content ItemORCID profile
Research website
Twitter@SamElOsta1
Section: Endocrinology and metabolic epigenetics
Specialisms: Epigenetics, DNA methylation, Chromatin, Histones, Gene Regulation, Human Disease, Cardiovascular Disease, T1D


Aging and Development Epigenetics

Section Editor

Akihiro Umezawa, MD, PhD, National Institute for Child Health and Development, Japan
New Content Item






Associate Editors

Sara Hägg, PhD, Karolinska Institutet, Sweden
New Content Item (1)ORCID profile
Research website
Twitter@HaggSara 
Specialisms: Aging epidemiology, Genetics, Epigenetic clocks



Nishino Koichiro, PhD, University of Miyazaki, Japan

Miina Ollikainen, FIMM, UH, University of Helsinki, Finland

Monika Puzianowska-Kuznicka, MD, PhD, Mossakowski Medical Research Institute, Poland


Wolfgang Wagner, MD, PhD, RWTH Aachen Medical School, Germany
ORCID Profile
Research website
Specialisms: DNA methylation, epigenetic clocks, epigenetic biomarkers in cancer




 

Allergy, Immunology, Pathogens and Inflammation
 

Section Editor

Boris Novakovic, PhD, Murdoch Children's Research Institute, Australia
New Content Item






Associate Editor
Gianluigi Franci, PhD, University of Salerno, Italy
Kari Nadeau, MD, PhD, FAAAAI, Harvard School of Public Health , USA


Cancer Epigenetics - Solid Tumors

Section Editors

Maria Berdasco, PhD, Josep Carreras Leukemia Research Institute (IJC), Spain
New Content Item 






Carmen Jerónimo, PhD, Portuguese Oncology Institute of Porto (IPO Porto) & University of Porto, Portugal 
New Content ItemORCID profile
Research website
Twitter@GEBC_IPOPorto
Specialisms: Cancer Epigenetics, Cancer epitranscriptomics, Biomarkers, Epidrugs, Molecular pathology, Precision oncology


Associate Editors

Nita Ahuja, MD, MBA, FACS, Yale University, USA
Tiziana Bonaldi, PhD, European Institute of Oncology, Italy
Rene Cortese, PhD, University of Missouri, USA
James M Flanagan, PhD, Imperial College London, UK
Thomas Fleischer, PhD, Oslo University Hospital, Norway
Mario F Fraga, PhD, Nanomaterials and Nanotechnology Center (CINN-CSIC), Health Research Institute of Asturias (ISPSA), Institute of Oncology of Asturias (IUOPA, University of Oviedo), Spain
Michèle J Hoffmann, PhD, Heinrich-Heine-University Duesseldorf, Germany
Bozena Kaminska, PhD, DSc, Nencki Institute of Experimental Biology, Poland
Gwen Lomberk, PhD, Medical College of Wisconsin, USA
Arpad Patai, MD, PhD, Semmelweis University, Hungary
Qian Tao, PhD, The Chinese University of Hong Kong, Hong Kong
Raul Urrutia, MD, Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, USA 
Stefan Wiemann, PhD, German Cancer Research Center-Heidelberg (DKFZ), Germany
Bea Wisman, PhD, University Medical Center Groningen, The Netherlands
Keishi Yamashita, MD, PhD, FACS, Kitasato University, Japan

 

Cancer Epigenetics – Hematological Malignancies


Section Editors

Joost Martens, PhD, Radboud Institute for Molecular Life Sciences, The Netherlands
New Content Item






Associate Editors
Heather Lee, BSc(Advanced) Hons I(Biochemistry), PhD, The University of Newcastle, Australia
Saad Z Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, USA
Makoto Yamagishi, PhD, The University of Tokyo, Japan

 

Cardiovascular epigenetics
 

Section Editor

Ronan Murphy, MD, CWSI, Dublin City University, Ireland
New Content Item






Associate Editors
Giuseppe Paolisso, MD, University of Campania "Luigi Vanvitelli", Italy
Elisabeth Zeisberg, PhD, University Medical Center Göttingen, Germany

 

Endocrinology and Metabolic Epigenetics


Section Editor

Sam El-Osta, PhD, Baker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Australia
New Content ItemORCID profile
Research website
Twitter@SamElOsta1
Section: Endocrinology and metabolic epigenetics
Specialisms: Epigenetics, DNA methylation, Chromatin, Histones, Gene Regulation, Human Disease, Cardiovascular Disease, T1D

Associate Editors
Christopher G. Bell, MBChB, PhD, FRCPA (Genetics), Queen Mary University of London, United Kingdom
Charlotte Ling, PhD, Lund University, Sweden
Richard Saffery, BSc, Grad Dip, PhD, Murdoch Children’s Research Institute, Australia

 

Environmental Epigenetics


Section Editor

Steven Gray, PhD, St James's Hospital, Ireland
New Content ItemORCID profile
Research website
Section: Environmental epigenetics
Specialisms: Lung Cancer, Mesothelioma, Biomarker, Epigenetics



Associate Editor
Andres Cardenas, PhD, Stanford University, USA

 

Epigenetic Biomarkers


Section Editor

Tomasz K Wojdacz, PhD, Pomeranian Medical University, Poland
New Content ItemORCID profile
Research website
Specialisms: Epigenetics, Methylation, Cancer, Biomarker, diagnosis, IVD 




Associate Editor
Harold Snieder, PhD, University Medical Center Groningen, The Netherlands
Andrew Teschendorff, PhD, Shanghai Institute for Nutrition and Health, Chinese Academy of Sciences, China

 

Epigenetic Technologies


Associate Editor
Albert Jeltsch, PhD, University of Stuttgart, Germany 
Aleksandar Vojta, PhD, University of Zagreb, Croatia

 

Epigenetic Therapies and Clinical Trials


Section Editors

Paola Arimondo, PhD, Centre National de la Recherche Scientifique, Institut Pasteur, France
New Content Item
ORCID profile
Research website
Twitter: @PbaEpiCBio1
Section: Epigenetic therapies and clinical trials
Specialisms: Chemical biology, Epigenetics, DNA, Histone


Associate Editors
Marc Diederich, PhD, College of Pharmacy, Seoul National University, South Korea
Antonello Mai, PhD, "Sapienza" Universitá di Roma, Italy
Richard Momparler, PhD, University of Montreal, Canada
Nick La Thangue, PhD, FRSE, FMedSci, University of Oxford, UK

 

Innovative Epigenetic Therapies


Section Editor

David Jay Segal, PhD, University of California-Davis, USA
New Content Item






 

Lifestyle Epigenetics


Section Editor

Wim Vanden Berghe, PhD, University of Antwerp, Belgium
New Content Item






Associate Editor
Andy T. Y. Lau, PhD, Shantou University Medical College, China

 

Neurology and Psychiatry Epigenetics


Section Editors

Jonathan Mill, PhD, University of Exeter and King's College London, UK
New Content Item






Jonathan Turner, PhD, Luxembourg Institute of Health, Luxembourg
New Content Item






Associate Editor
Riccardo Marioni, PhD, University of Edinburgh, UK

 

Regenerative medicine


Section Editor

Adele Murrell, PhD (CANTAB), University of Bath, UK
New Content Item






 

Reproductive and Transgenerational Epigenetics


Section Editor

Eamonn Maher, PhD, University of Cambridge, UK
New Content Item






Associate Editor
Miguel Constancia, MSc, PhD, University of Cambridge, UK
Jacquetta Trasler, MD, PhD, McGill University Health Centre, Canada

 

Respiratory Epigenetics


Section Editor

John W Holloway, PhD, University of Southampton, UK
New Content ItemORCID profile
Research website
Twitter@ProfJWHolloway
Section: Respiratory Epigenetics
SpecialismsAsthma, Allergy, Respiratory, Genomics, Epigenetics


Associate Editors
Dawn L. DeMeo, MD, MPH, Brigham and Women's Hospital/ Harvard Medical School, USA


Statisticians
Lingeng Lu, MD, PhD, Yale University, USA
Harold Snieder, PhD, University Medical Center Groningen, The Netherlands


Editorial Board
Lorena Aguilar Arnal, PhD, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México
Alfonso Baldi, MD, Università della Campania Luigi Vanvitelli, Italy
Steven Belinsky, PhD, Lovelace Respiratory Research Institute, USA
Rosaria Benedetti, PhD, RTDA, Universitá degli Studi della Campania "Luigi Vanvitelli", Italy
Nathalie Bérubé, PhD, Western University, Canada
Pilar Blancafort, BSc, PhD, The Harry Perkins Institute of Medical Research & University of Western Australia, Australia
Miguel Branco, PhD, Queen Mary University of London, UK
Robert Brown, Imperial College London, UK
Kyle J Burghardt, PharmD, Wayne State University, USA
Katherine Chiappinelli, PhD, George Washington University, USA
James Chim, MD, PhD, University of Hong Kong, Hong Kong
Gianluigi Condorelli, PhD, Humanitas University, Italy
Fabio Coppedè, MSc, PhD, University of Pisa, Italy
Christos Damaskos, MD, MSc, PhD, University of Athens, Greece
Soner Dogan, PhD, Yeditepe University, Turkey
Thomas Eggermann, PhD, RWTH Aachen, Germany
Karl Ekwall, PhD, Karolinska Institutet, Sweden
Frank O Fackelmayer, PhD, Institute of Molecular Biology and Biotechnology IMBB-Forth, Greece
Huitao Fan, PhD, Harbin Medical University, China
Mirco Fanelli, BSc, University of Urbino "Carlo Bo," Italy
Robert Feil, PhD, CNRS and University of Montpellier, France
Roger Foo, MD, Genome Institute of Singapore, Singapore
François Fuks, PhD, Université libre de Bruxelles, Belgium
Andrea Fuso, PhD, Sapienza University of Rome, Italy
Peter Gluckman, The Liggins Institute of Medical Research, New Zealand
Antonio Gómez, PhD, University of Vic – Central University of Catalonia, Spain
Joel Gottesfeld, PhD, The Scripps Research Institute, USA
Monika Hegi, PhD, Lausanne University Hospital, Switzerland
Ricky Johnstone, PhD, Peter MacCallum Cancer Centre, Australia
Meaghan Jones, PhD, University of Manitoba, Canada
Renata Jurkowska, PhD, Cardiff University, UK
Masayo Kagami, MD, PhD, National Research Institute for Child Health and Development, Japan
Yutaka Kondo, MD, PhD, Nagoya City University Graduate School of Medical Sciences, Japan
Ah-Ng Tony Kong, PhD, Rutgers University, USA
Maria Lerm, PhD, Linköping University, Sweden
Haitao Li, BSc, PhD, Tsinghua University, China
Lili Li, PhD, The Chinese University of Hong Kong, Hong Kong
Carine Van Lint, MD, PhD, University of Brussels (ULB), Belgium
Michael Lübbert, PhD, Universitätsklinikum Freiburg, Germany
Deborah JG Mackay, PhD, Southampton University Hospital, UK
Patrick O McGowan, PhD, University of Toronto, Canada
Michele A La Merrill, PhD, MPH, University of California-Davis, USA
Saverio Minucci, MD, IFOM - IEO, Italy
David Monk, PhD, Institut d'Investigació Biomèdica Bellvitge, Spain
Pamela Munster, MD, University of California, USA
Clara Nervi, MD, PhD, University of Rome La Sapienza, Italy
Andreas Neubauer, MD, Philipps Universität Marburg, Germany
Stephen Nimer, MD, University of Miami, USA
Jan Postberg, PhD, Witten/Herdecke University, Germany
H Llewelyn Roderick, BSc, PhD, KU Leuven, Belgium
Olivier Rohr, University of Strasbourg, France
Sabrina Ruhrmann, PhD, Lund University, Sweden
Lucas A Salas, MD, MPH, PhD, Geisel School of Medicine at Dartmouth College, USA
Paola Scaffidi, PhD, The Francis Crick Institute and UCL Cancer Institute, UK
Huidong Shi, PhD, Georgia Cancer Center, Medical College of Georgia, Augusta University, USA
Gustavo Turecki, MD, PhD, McGill University, Canada
Toshikazu Ushijima, MD, PhD, National Cancer Center Research Institute, Japan
Eric Verdin, MD, PhD, J David Gladstone Institutes, USA
Olaf Witt, German MD, Cancer Research Center, Germany
Chi-Ming  Wong, PhD, The Hong Kong Polytechnic University, Hong Kong
Suowen Xu, PhD, University of Science and Technology of China, China
Vlatka Zoldos, PhD, University of Zagreb, Croatia


Trusted Reviewers
Evelien V. Assche, PhD, Universitätsklinikum Münster, Germany
Amitava Basu, PhD, Institute of Molecular Biology, Germany
Surajit Bhattacharya, PhD, Children’s National Health System, USA
Maria Pia Campagna, PhD, Monash University, Australia
Claudio Cappelli, PhD, Austral University, Chile
Ji-Qing Chen, PhD, Dartmouth College, USA
Bradley M Downs, PhD, Johns Hopkins University, USA
Louis Y El Khoury, PhD, Mayo Clinic, USA
Miguel Ensenyat-Mendez, PhD, Balearic Islands Health Research Institute, Spain
Jayashri Ghosh, PhD, Temple University, USA
Takanobu Inoue, PhD, National Center for Child Health and Development, Japan
Prachand Issarapu, PhD, Centre for Cellular and Molecular Biology, UK
Diana L Juvinao-Quintero, PhD, Harvard University, USA
Yu-Chin Liu, PhD, Chang Gung University, Taiwan
Catarina Macedo-Silva, PhD, Instituto Português de Oncologia do Porto, Portugal
Tamas Micsik, PhD, Semmelweis University, Hungary
Laura Pignata, PhD, University of Campania "Luigi Vanvitelli", Italy
Anup Sharma, PhD, Yale University, USA
Youssef Siblini, PhD, University of Lorraine, France
Gurdeep Singh, PhD, The Provincial Health Services (PHSA), Canada
Sumi Surendran, PhD, Rajiv Gandhi Centre for Biotechnology, India
Anna Syreeni, PhD, University of Helsinki, Finland
Joseph Wragg, PhD, University of Birmingham, UK